Reviewing the latest HIV-research-related publications together with BIOMEDICA CRO 🧬

Researchers from the University of Illinois have delved into the intricacies of HIV treatment, shedding light on the importance of cell-type-specific targeting. Their groundbreaking study examines the differential effects of HIV latency modulation on myeloid cells, a crucial component of the immune system originating from bone marrow. Alexandra Blanco, a Ph.D. student in Collin Kieffer’s laboratory, created a clonal library comprising 70 populations of latently infected monocytes. She analyzed these clonal populations and their responses to activation, revealing significant variations and highlighting the diverse nature of a single cell type.

“We aim to broaden our investigation to encompass T-cells, monocytes, and macrophages, identifying potential drugs with broad applicability across various cell types,” Blanco remarked.

Please find more information about this research on the PNAS website, article “Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation”.

In light of these developments, we at BIOMEDICA CRO want to highlight our readiness to assist with preclinical stage projects by providing high-quality human biological specimens and comprehensive clinical data obtained from subjects confirmed positive for HIV and other diseases.

How does BIOMEDICA CRO support viral infectious diseases research?🩸

At BIOMEDICA CRO, we do biosample procurement through a broad network of partnered hospitals in Ukraine, and we have been supplying them globally since 2017. Having a network of 50+ direct contracts with hospitals in Ukraine in many disease areas, we are ready to support infectious, oncology and various therapeutic diseases research.
For instance, thanks to cooperation with physicians from Infectious departments, we can involve patients who confirmed positive for Human Immunodeficiency viruses (HIV), Hepatitis B (HBV), Hepatitis C (HCV), Syphilis, and other conditions. After volunteers sign the Individual Consent Form, we can obtain the following specimens for further research:

Up to 40-50 ml of whole blood that can be processed into various components, such as plasma, buffy coat, serum, or PBMC;
~1-3 ml of saliva;
~50-100 ml of urine;
Several buccal/other swabs, etc.

All human biospecimen types we provide are collected under the internal company SOPs as well as considering your particular recommendations. Our experienced study managers align all project steps with your unique needs. In addition to collecting human biosamples, we can also provide precise clinical data, laboratory test results, and other valuable information from each donor involved in our projects to assist you in achieving your research goals.

⏱️As our main focus is on prospective customized studies, we want you to know that it usually takes only 1-2 weeks to initiate a prospective collection after receiving a Purchase Order. During this period, we focus on preparing project documentation, assembling collection kits, and conducting training sessions with our medical staff. Please rest assured that we are dedicated to commencing biospecimen collection promptly, ensuring efficiency, and respecting our Customers` valuable time.

If you need a reliable partner to source HIV-positive biospecimens or other human biosamples for your research, BIOMEDICA CRO is here to help.

📩 Please email us to start our collaboration and order biospecimens at office@biomedica-cro.com.
BIOMEDICA CRO team is fully committed to supporting you in every step of your journey. We would be delighted to discuss your project in detail, address any inquiries you may have, and tailor our support to meet your research goals.

🌐 Clicking here, you can explore our extensive range of banked biological samples.

🚀 Follow us on LinkedIn to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of human biospecimen procurement. Together, let’s drive innovation and make remarkable discoveries.